Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders.
The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives.
Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,800 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb.
European Contact: email@example.com
USA Contact: firstname.lastname@example.org
Webinar presented by Sotiri Stathakis, PhD, Associate Professor of Radiation Oncology and Radiology, University of Texas Health Science Center. Monday 18 April 2016, 9am CDT.
Webinar presented by Doug Moseley PhD, Assistant Professor, Department of Radiation Oncology, University of Toronto.
Company debuts work-in-progress helium recycler for Elekta Neuromag® TRIUX™ MEG system at 2014 American Epilepsy Society meeting
Webinar presented by David Shepard PhD (Director of Medical Physics, Swedish Cancer Institute)
Advanced treatment system now available in Elekta’s second largest market.